IPHA

Innate Pharma
IPHA

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$2
7% downside
High target

1 analyst rating

positive
1  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Leerink Partners
Leerink Partners
Daina Graybosch
18 Sep ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Swayampakula Ramakanth
71% 1-yr IPHA win rate
18 Sep ‘25 1 month ago